Tags: Drug.

Marimastat was a proposed antineoplastic drug developed by British Biotech. It acted as a broad-spectrum matrix metalloproteinase inhibitor.Marimastat performed poorly in clinical trials and development was terminated.[citation needed]

Marimastat.png
ATC prefix
none
CAS number
154039-60-8
DrugBank
DB00786
FDA UNII code
D5EQV23TDS
IUPAC name
N-[22-dimethyl-1- (methylcarbamoyl)propyl]-2- [hydroxy-(hydroxycarbamoyl)methyl]- 4- methyl-pentanamide
PubChem
119031

Loading...

This page contains content from the copyrighted Wikipedia article "Marimastat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.